Replies to post #145965 on Innovation Pharmaceuticals Inc (IPIX)

[I Need Help]

Just took a quick look at the OTC Markets web site, CTIX has just a bit over 700K shares shorted compared with over 1M several months ago (data as of 3/31).

My take is that shorts will be exiting as CTIX gets more expensive. But, there will always be short interest, much of which will be churning from hand to hand.

My take is that MM's contribute most of the normal daily short sales. They often roll their positions forward from day to day. They use shorting as a tool to satisfy buy orders. MM's typically do not have deep pools of shares on hand. On major run ups, shorting will likely increase as MM's will need to short more to cover the velocity in buying.

My take is that 25% to 33% daily shorting is pretty typical for CTIX. My take is that it is highly unlikely that daily shorting will ever significantly decrease below 25%.

Daily shorting is not cumulative. Otherwise, how could one explain decreasing monthly totals and 25%+ daily shorts.

I mentioned in a recent post that almost all too successful companies face short attacks as their valuations become too rich. CTIX is far from being fairly or overly priced; thus, an unlikely candidate for an imminent short attack. I suppose the short attack of over a year ago should be a wake up call for the next time CTIX doubles or triples in a relatively short timespan. By then, CTIX should be in better shape regarding fighting off a real Bear attack.

By litigating the ongoing Rosen case, CTIX is making it clear that any future legal prong to a Bear attack will be defended against.

By calling out Seeking Alpha, CTIX has made the case that SA articles need to be vetted before accepted by readers, the media prong to a Bear attack.

By being more transparent, and by being more precise in communications; CTIX has limited its exposure to liability, which could fuel a Bear attack.

More needs to be done; up listing, an independent (highly qualified and respected) BOD, a professional PR representative, and partnerships. Financing is a bit trickier; but, stronger is better.

Lastly, the science. All is looking good. Management needs to continue keeping everything on track. Management needs to be transparent with shareholders. Shareholders deserve to know what is material, and in a timely fashion; regardless of potential outlook.